4
Changes in Ownership
ADMA BIOLOGICS, INC. Filed Acc 0001140361-25-019589
President and CEO sold 21,000 shares at $19.45 ($408,450)
- President and CEO acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Grossman Adam S · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,000 | $5.40 | $81,000 | 2,070,850 | D |
| 2025-05-15 | Sale : show line 2 in the form 10b5-1 | −15,000 | $19.45 | $291,750 | 2,055,850 | D |
| 2025-05-15 | Sale : show line 3 in the form 10b5-1 | −6,000 | $19.45 | $116,700 | 2,049,850 | D |
| Open-market sales · 21,000 sh · avg $19.45 · $408,450 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-15 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −15,000 | 825,950 | D |
Loading xslF345X05/form4.xml…